echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Harbin Sanlian entered the administrative examination and approval stage with the imitation of the 4 types of flurbiprofen gel plaster reported for production

    Harbin Sanlian entered the administrative examination and approval stage with the imitation of the 4 types of flurbiprofen gel plaster reported for production

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
    .
    According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
    7 billion yuan in 2020, a year-on-year increase of nearly 30%

    .
     
     
     Source: official website of the State Food and Drug Administration
     
      Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
    It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
    It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain

    .
     
      At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
    According to data from Meinenet, the product will be used in urban public
    hospitals , county-level public hospitals, and urban communities in China in 2020 .
    The
    total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical
    pharmacies exceeded 1.
    7 billion yuan, a year-on-year increase of nearly 30%

    .
     
      Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
    It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
    09%

    .
     
      2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
    Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
    In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year

    .
     
      Source: Meinenet database, official website of the State Drug Administration, etc.
      Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
    .
    According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
    7 billion yuan in 2020, a year-on-year increase of nearly 30%

    .
     
     
     Source: official website of the State Food and Drug Administration
     
      Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
    It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
    It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain

    .
     
      At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
    According to data from Meinenet, the product will be used in urban public
    hospitals , county-level public hospitals, and urban communities in China in 2020 .
    The
    total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical
    pharmacies exceeded 1.
    7 billion yuan, a year-on-year increase of nearly 30%

    .
     
      Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
    It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
    09%

    .
     
      2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
    Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
    In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year

    .
     
      Source: Meinenet database, official website of the State Drug Administration, etc.
      Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
    .
    According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
    7 billion yuan in 2020, a year-on-year increase of nearly 30%

    .
     
     
     
     Source: official website of the State Food and Drug Administration
     
      Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
    It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
    It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain

    .
     
      At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
    According to data from Meinenet, the product will be used in urban public
    hospitals , county-level public hospitals, and urban communities in China in 2020 .
    The
    total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical
    pharmacies exceeded 1.
    7 billion yuan, a year-on-year increase of nearly 30%

    .
    Enterprise enterprise enterprise hospital hospital hospital pharmacy pharmacy pharmacy
     
      Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
     
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
    It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
    09%

    .
     
      2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
      
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
    Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
    In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year

    .
     
      Source: Meinenet database, official website of the State Drug Administration, etc.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.